Paragraph 1: BGI and CITIC Securities are two famous enterprises in China, and they have made outstanding achievements in different fields. Huada Gene is a high-tech enterprise focusing on life science and medical health, which is famous for its gene sequencing technology and medical device products. CITIC Securities is one of the leading enterprises in China's financial industry, and its business scope covers securities, trust, asset management, investment banking and other fields.

The second paragraph: Although BGI and CITIC Securities have different business fields, the two companies have a lot of cooperation in strategic cooperation. It is understood that CITIC Securities is one of the few strategic placing targets for BGI to issue A shares in 2019, and it won about 654.38+0.5 billion yuan in BGI's share purchase plan. This further strengthened the cooperation between the two companies and provided a new opportunity for the layout of CITIC Securities in the high-tech field.

Paragraph 3: At the same time, the cooperation between BGI and CITIC Securities is still deepening. It is reported that BGI and CITIC Securities jointly set up the "BGI CITIC Fund", aiming at combining scientific and technological innovation with capital operation, optimizing resource allocation and promoting the further development of high-tech industries in China. I believe that with the joint efforts of both sides, this cooperation will inject new impetus into the development of high-tech industries in China and make positive contributions to the economic transformation and upgrading of China.